Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GPR37 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
mRNA | CCNF | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
mRNA | SRP72 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
mRNA | CLIP4 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
mRNA | DDX51 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
mRNA | ZNF324B | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
mRNA | CNTLN | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
mRNA | C4orf46 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
mRNA | TMEM167A | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
mRNA | INHA | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |